Patient preferences for gene therapy in haemophilia: Results from the PAVING threshold technique survey-Reference-Cited by-同舟云学术

Patient preferences for gene therapy in haemophilia: Results from the PAVING threshold technique survey

Published:2021-09 Issue:6 Volume:27 Page:957-966
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Overbeeke Eline¹^ORCID,Hauber Brett²³,Michelsen Sissel¹,Peerlinck Kathelijne⁴,Lambert Catherine⁵^ORCID,Hermans Cedric⁵^ORCID,Lê Phu Quoc⁶,Goldman Michel⁷,Simoens Steven¹,Huys Isabelle¹

Affiliation:

1. Clinical Pharmacology and Pharmacotherapy University of Leuven Leuven Belgium

2. Health Preference Assessment RTI Health Solutions Research Triangle Park North Carolina USA

3. Comparative Health Outcomes Policy and Economics (CHOICE) Institute University of Washington School of Pharmacy Seattle WA USA

4. Haemophilia Centre UZ Leuven Leuven Belgium

5. Haemophilia Clinic St‐Luc University Hospital Brussels Belgium

6. Hémato‐Oncologie Hôpital Universitaire des Enfants Reine Fabiola Brussels Belgium

7. Institute for Interdisciplinary Innovation in healthcare Université libre de Bruxelles Brussels Belgium

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.14401

Reference44 articles.

1. Gene therapy: evidence, value and affordability in the US health care system

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The benefits of gene therapy in people with haemophilia;Journal of Viral Hepatitis;2024-04

2. Exploring patient and clinician perspectives on the benefits and risks of emerging therapies for the treatment of haemophilia: a qualitative study;The Journal of Haemophilia Practice;2024-01-01

3. Research Priorities to Increase Confidence in and Acceptance of Health Preference Research: What Questions Should be Prioritized Now?;The Patient - Patient-Centered Outcomes Research;2023-12-16

4. Perspectives and perception of haemophilia gene therapy by French patients;Haemophilia;2023-12-06

5. How can patient preferences be used and communicated in the regulatory evaluation of medicinal products? Findings and recommendations from IMI PREFER and call to action;Frontiers in Pharmacology;2023-08-16